Role of nitric oxide-induced immune suppression in toxoplasmosis during pregnancy and in infection by a virulent strain of Toxoplasma gondii.
Candolfi
E
E
Institut de Parasitologie et de Pathologie Tropicale de la Faculté de Médecine de Strasbourg, France.
Villard
O
O
Thouvenin
M
M
Kien
T T
TT
D000818:Animals; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy; D051379:Mice; D009569:Nitric Oxide / Q000276:immunology*; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D014122:Toxoplasma / Q000276:immunology / Q000472:pathogenicity*; D014123:Toxoplasmosis / Q000276:immunology*; D014124:Toxoplasmosis, Animal / Q000276:immunology*; D014774:Virulence
D009569:Nitric Oxide